Fundraising Fox

March Biosciences

Houston, US · Founded 2021 · Delaware corporation · 8 known investors

march.bio ↗

March Bioscience is a cell therapy company assembling leading scientists and drug developers to advance cell therapy treatments. The company focuses on developing therapeutics in the cell and gene therapy space.

BiotechMedical Devicesin /march.biosciences

Founders & leadership

SH
Sarah HeininCEO, Co-Founder
MM
Maksim MamonkinCo-Founder, Chair Scientific Advisory Board
MB
Malcolm BrennerCo-founder
TL
Thomas LubyinDirector
PO
Peter OlagunjuinDirector
JP
Joseph PetrosinoDirector

Investors · 8

Mission Biocapital✓ verifiedSan Francisco · $500K
4BIO Capital✓ verifiedLondon
Cancer FundPhoenix
Modi VenturesHouston
Portal InnovationsChicago
TMC Venture FundHouston
Fitz Gate VenturesreportedHouston · $500K – $1M
KdT Venturesreported · 2 sourcesAustin · $500K – $3M

Reported raises · per SEC filings

Form D private placements
▶$22.1MraisedOct 2024 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas LubyDirector
  • Peter OlagunjuDirector
  • Joseph PetrosinoDirector
  • Sarah HeinDirector, Executive Officer
  • Maksim MamonkinDirector, Executive Officer
Offering amount
$22.1M
Amount sold
$22.1M
First sale
Oct 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.9KraisedSep 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sarah HeinExecutive Officer, Director
Offering amount
$8.9K
Amount sold
$8.9K
Minimum investment
$8.9K
First sale
Sep 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news